NCT07381036
Nebulized Ketamine Versus Nebulized Magnesium Sulfate Versus Placebo for the Prevention of Postoperative Sore Throat .
StatusActive, Not Recruiting
PhaseNot applicable
SponsorSohag University
Primary completion (estimated)
At risk: Primary completion moved 5 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 2 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 11 words Show 6 more changesShow less
- Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Primary completion pushed from Jul 1, 2026 to Dec 1, 2026
- Final enrollment: 171 participants (planned 150)
- Study completion pushed from Sep 1, 2026 to Dec 30, 2026
- Study sites: 0 to 1
- Study title expanded, about 1 word
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
To compare the incidence of Post operative sore throat method.
Timeframe: 24 hours
Arms and interventions
Ketamine groupExperimental
Mg sulfate groupExperimental
Placebo groupPlacebo comparator
Drugs: Ketamine nebulizer, Mg sulfate nebulizer, Placebo
Sites
1 site in 1 country
- Sohag University HospitalSohag, Sohag Governorate, Egypt